Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0
List of links present in page
- https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0